Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Therma Bright Inc (TSV: THRM )

0.0300 UNCHANGED
Streaming Delayed Price Updated: 2:37 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Therma Bright Inc

< Previous 1 2 3 Next >
Therma Bright Provides Update on Venowave's Permanent CPT/HCPCS Codes and United States Distribution Partners
Toronto, Ontario--(Newsfile Corp. - August 4, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Therma Bright Provides Update on Venowave for the United States and Texas Region
Toronto, Ontario--(Newsfile Corp. - June 30, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Therma Bright Investigates Remote Therapeutic Monitoring (RTM) Reimbursement for its AI-Driven Digital Cough Technology
Toronto, Ontario--(Newsfile Corp. - June 22, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Therma Bright's Investment Partner Inretio Announces Successful Completion of GLP Study for PREVA(TM) Thrombectomy Device
Tel Aviv, Israel and Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma"... 
Via Newsfile
Therma Bright Expands U.S. Distribution of Venowave Device to Increase Sales Under Temporary CPT(R) & HCPCS Codes
Toronto, Ontario--(Newsfile Corp. - May 25, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Therma Bright Initiates Data Collection with AI Digital Cough Technology App at TB Clinics
Toronto, Ontario--(Newsfile Corp. - May 10, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Topics Artificial Intelligence Death
Exposures Artificial Intelligence COVID-19 Death
Therma Bright Milestone Payments Bring Ownership in Inretio to 7.5%
Toronto, Ontario--(Newsfile Corp. - April 21, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"),... 
Via Newsfile
Therma Bright Secures Medicare and Medicaid Reimbursement for Venowave Device
Toronto, Ontario--(Newsfile Corp. - April 14, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Therma Bright Prepares Launch of Digital Cough Screening and Data Collection Smartphone Application
Toronto, Ontario--(Newsfile Corp. - March 23, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
Therma Bright's Investment Partner Inretio Moves to New Manufacturing Facility
Toronto, Ontario--(Newsfile Corp. - March 8, 2023) - Investor partner Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the... 
Via Newsfile
Exposures Product Safety
Therma Bright Reports on Progress of Inretio's Novel Clot Removal Device for Stroke Treatment
Toronto, Ontario--(Newsfile Corp. - February 23, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Therma Bright Secures Exclusive License Agreement for AI4LYF's Patent-Pending Digital Cough Technology (DCT) to Detect Respiratory Diseases
Toronto, Ontario--(Newsfile Corp. - February 16, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"),... 
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Therma Bright Inc. Invests in Ischemic Stroke Blood Clot Retriever Technology Company Inretio Inc. based in Israel
Toronto, Ontario--(Newsfile Corp. - January 19, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"),... 
Via Newsfile
Exposures COVID-19
Therma Bright Provides 2022 Year End Update
Toronto, Ontario--(Newsfile Corp. - December 21, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Invests in the Development of Novel Treatments for COVID-19, Asthma, and Chronic Obstructive Pulmonary Disease (COPD)
Toronto, Ontario--(Newsfile Corp. - December 1, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Therma Bright Inc. to Acquire an Exclusive License for a Patented Digital Cough Based Technology to Detect Respiratory Diseases
Toronto, Ontario--(Newsfile Corp. - November 17, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"),... 
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19 Product Safety
Therma Bright Receives New Billing Codes for Venowave Allowing for Reimbursement from Medicare, Medicaid, and Private Insurers
Toronto, Ontario--(Newsfile Corp. - October 27, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Exposures COVID-19
Therma Bright Receives Payment for Initial Venowave Sales
Toronto, Ontario--(Newsfile Corp. - September 20, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Topics Supply Chain
Exposures COVID-19 Supply Chain
Therma Bright Provides Update on FDA EUA Review Process
Toronto, Ontario--(Newsfile Corp. - September 12, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its... 
Via Newsfile
Topics Supply Chain
Exposures COVID-19 Product Safety Supply Chain
Therma Bright Provides Progress Update on FDA EUA & Health Canada Interim Order Applications for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test
Toronto, Ontario--(Newsfile Corp. - August 4, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Submits Health Canada Application for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test for Point-of-Care (POC)
Toronto, Ontario--(Newsfile Corp. - June 23, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Provides Update on FDA EUA Application Process For AcuVid(TM) COVID-19 Rapid Antigen Saliva Test
Toronto, Ontario--(Newsfile Corp. - June 2, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the... 
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright to Submit Application to Health Canada for Approval of its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test
Toronto, Ontario--(Newsfile Corp. - May 10, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical... 
Via Newsfile
Topics Supply Chain
Exposures COVID-19 Product Safety Supply Chain
Therma Bright Ships Initial Venowave Order to US Distributor
Toronto, Ontario--(Newsfile Corp. - April 28, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical... 
Via Newsfile
Exposures COVID-19
Therma Bright Submits AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Application for U.S. Food & Drug Administration's Emergency Use Authorization (EUA)
Toronto, Ontario--(Newsfile Corp. - March 29, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Receives Patent for a Device for Applying a Topical Treatment from U.S. Patent & Trademark Office (USPTO)
Toronto, Ontario--(Newsfile Corp. - February 23, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Therma Bright's AcuVid(TM) U.S. Clinical Performance Study Successfully Exceeds U.S. Food & Drug Administration's Emergency Use Authorization Requirements
Toronto, Ontario--(Newsfile Corp. - February 15, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Completes U.S. Clinical Performance Study Subject Recruitment
Toronto, Ontario--(Newsfile Corp. - January 31, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Provides Update on U.S. Clinical Performance Study
Toronto, Ontario--(Newsfile Corp. - January 20, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright AcuVid(TM) COVID-19 Rapid Antigen Saliva Test's Antibodies Successfully Detect the COVID-19 Omicron B.1.1.529 Variant
Toronto, Ontario--(Newsfile Corp. - December 16, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its... 
Via Newsfile
Exposures COVID-19
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.